Hirayama disease is a rare condition of cervical myelopathy. Its early identification and correction can optimize functional outcomes. However, late presentation and some more severe cases may be associated with loss of hand function. Among the cases described, there are no reports of nerve transfers for this condition. We presented the first case report of a Hirayama disease of isolated ulnar nerve impairment managed with nerve transfer. Electroneuromyography showed isolated preganglionic involvement of C7, C8, and T1, with no sensory changes. The patient underwent nerve transfer with anterior interosseous nerve to ulnar nerve supercharge end-to-side, recovering hand function in 7 months.
HirayamaKToyocuraYTsubakiT.Juvenile muscular atrophy of unilateral extremity: a new entity. Jpn J Psychiatry Neurol. 1959;61:2190-2197.
4.
VermaRLallaRPatilTB, et al. Hirayama disease: a frequently undiagnosed condition with simple inexpensive treatment. BMJ Case Rep. 2012;2012:1-5.
5.
ChibaSYonekuraKNonakaM, et al. Advanced Hirayama disease with successful improvement of activities of daily living by operative reconstruction. Intern Med. 2004;43(1):79-81.
6.
HassanKMSahniHJhaA.Clinical and radiological profile of Hirayama disease: a flexion myelopathy due to tight cervical dural canal amenable to collar therapy. Ann Indian Acad Neurol. 2012;15(2):106-112.
7.
HuangYCRoLSChangHS, et al. A clinical study of Hirayama disease in Taiwan. Muscle Nerve. 2008;37(5):576-582.
8.
AgundezMRoucoIBarcenaJ, et al. Enfermedad de Hirayama: ¿operar o no operar?Neurología. 2015;30:502-509.
9.
BarbourJYeeAKahnLC, et al. Supercharged end-to-side anterior interosseous to ulnar motor nerve transfer for intrinsic musculature reinnervation. J Hand Surg Am. 2012;37(10):2150-2159.
